US cosmetic surgery product demand will grow 8.4 percent annually through 2012, driven by ongoing desires for a youthful appearance and an aging population. Less invasive procedures (e.g., injections, laser dermal resurfacing) will grow the fastest. Implants and other surgical products will do well where there are no significant alternatives.
This study analyzes the $1.9 billion US cosmetic surgery product industry. It presents historical demand data (1997, 2002 and 2007) and forecasts for 2012 and 2017 by procedure (e.g., surgical, nonsurgical), product (e.g., equipment, injectables, implants, wound care disposables) and raw material (e.g., microbial extracts, collagen, polymers).
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 33 industry players, including Allergan, Mentor and Medicis.
